» Authors » Mostafa Moradi Sarabi

Mostafa Moradi Sarabi

Explore the profile of Mostafa Moradi Sarabi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 29
Citations 184
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Babaeenezhad E, Khosravi P, Moradi Sarabi M
Genes Nutr . 2025 Mar; 20(1):2. PMID: 40038577
Background: Promoter methylation silencing of peroxisome proliferator-activated receptor gamma (PPARγ) and dysregulation of the PPARγ/COX2 axis contribute to colorectal cancer (CRC) pathogenesis. This study investigated for the first time the...
2.
Rashidipour M, Abbaszadeh S, Birjandi M, Pajouhi N, Ahmadi Somaghian S, Goudarzi G, et al.
Sci Rep . 2024 Dec; 14(1):30405. PMID: 39638815
Tannic acid (TA) is a potent antitumor agent, but its low bioavailability and absorption limit its use. In this study, it was loaded into chitosan-based nanoparticles (Chi-NPs) to overcome these...
3.
Karimi Y, Rashidipour M, Iranzadasl M, Ahmadi M, Moradi Sarabi M, Farzaneh F
BMC Complement Med Ther . 2024 Nov; 24(1):398. PMID: 39543581
Background: Biofilm formation has a crucial role in the cariogenic virulence of Streptococcus mutans, which leads to resistance to common antibacterials. The antimicrobial resistance crisis has led to increased research...
4.
Moghadasi M, Taherimoghaddam M, Babaeenezhad E, Birjandi M, Kaviani M, Moradi Sarabi M
Diabetes Metab Syndr . 2024 Nov; 18(10):103156. PMID: 39522431
Aims: This study aimed to investigate the roles of DNA methylation and miR-34a in the regulation of peroxisome proliferator-activated receptor gamma (PPARγ) in patients with type 2 diabetes (T2D). Methods:...
5.
Babaeenezhad E, Abdolvahabi Z, Asgharzadeh S, Abdollahi M, Shakeri S, Moradi Sarabi M, et al.
Pathol Res Pract . 2024 Jul; 260:155454. PMID: 39002434
Breast cancer (BC) is a major public health problem that affects women worldwide. Growing evidence has highlighted the role of miRNA-206 in BC pathogenesis. Changes in its expression have diagnostic...
6.
Babaeenezhad E, Dezfoulian O, Moradi Sarabi M, Ahmadvand H
Naunyn Schmiedebergs Arch Pharmacol . 2024 Jan; 397(8):5701-5714. PMID: 38294506
The clinical use of gentamicin (GM) is restricted by its nephrotoxic effects. This study aimed for the first time to elucidate the ameliorative effects of the monoterpene linalool (Lin) against...
7.
Babaeenezhad E, Rashidipour M, Jangravi Z, Moradi Sarabi M, Shahriary A
Int J Biol Macromol . 2024 Jan; 260(Pt 2):129618. PMID: 38253156
Poor bioavailability, solubility, and absorption of berberine (Ber) limit its widespread application. Here, we formulated novel chitosan/pectin nanoparticles (NPs) loaded with Ber to address delivery problems and promote the anticancer...
8.
Tarhriz V, Abkhooie L, Moradi Sarabi M
Curr Cardiol Rev . 2023 Apr; 19(5):51-56. PMID: 37005512
Today, we see an increase in death due to cardiovascular diseases all over the world, which has a lot to do with the regulation of oxygen homeostasis. Also, hypoxia-inducing factor...
9.
Babaeenezhad E, Moradi Sarabi M, Rajabibazl M, Oraee-Yazdani S, Karima S
Mol Biol Rep . 2022 Nov; 50(1):589-597. PMID: 36355265
Background: The relationship between peroxisome proliferator-activated receptor gamma (PPARγ) expression level and epigenetic modifications occurring in glioblastoma multiforme (GBM) pathogenesis is largely unknown. Herein, we examine the association of PPARγ...
10.
Babaeenezhad E, Naghibalhossaini F, Rajabibazl M, Jangravi Z, Hadipour Moradi F, Fattahi M, et al.
Noncoding RNA . 2022 Oct; 8(5). PMID: 36287119
Digestive tract cancers represent a serious public health issue. In recent years, evidence has accumulated that microRNA miR-185 is implicated in the pathogenesis of this group of highly malignant tumors....